Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel
Journal cover image

Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma.

Publication ,  Journal Article
Rucker, AJ; Raman, V; Jawitz, OK; Rhodin, KE; Tong, BC; Harpole, DH; D'Amico, TA
Published in: Ann Thorac Surg
March 2022

BACKGROUND: Endoscopic resection (ER) is the preferred treatment for superficial esophageal cancer; however, a safe time frame for performing ER has not been established. This study evaluated the period in which ER can be performed for patients with stage I esophageal adenocarcinoma without compromising outcomes. METHODS: The 2004-2015 National Cancer Database was used to identify patients with cT1 N0 M0 esophageal adenocarcinoma who underwent upfront ER. The primary outcome was overall survival, which was evaluated using Kaplan-Meier and multivariable Cox proportional hazards methods. The secondary outcome was rate of margin-positive resection, which was evaluated using a multivariable logistic regression. RESULTS: A total of 983 patients met study criteria. The median time from diagnosis to ER was 34 days (interquartile range, 5-70 days). Patients in the highest quartile of time to ER were more likely to be treated at a high-volume center and at a center different from that of diagnosis compared with those in the lowest quartile. Increasing time to ER was not independently associated with survival (adjusted hazard ratio per 10 days, 1.02; 95% confidence interval, 0.98-1.05; P = .32) or margin-positive resection (odds ratio per 10 days 1.01; 95% confidence interval, 0.96-1.06; P = .60). CONCLUSIONS: In this National Cancer Database analysis, increasing time to endoscopic resection, up to 180 days from diagnosis, was not associated with worsened survival or increased odds of margin-positive resection in patients with cT1 N0 M0 esophageal adenocarcinoma. Given these findings, patients may be afforded time to be seen in specialty centers without risk of tumor progression.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

March 2022

Volume

113

Issue

3

Start / End Page

942 / 948

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Neoplasm Staging
  • Humans
  • Esophagectomy
  • Esophageal Neoplasms
  • Adenocarcinoma
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rucker, A. J., Raman, V., Jawitz, O. K., Rhodin, K. E., Tong, B. C., Harpole, D. H., & D’Amico, T. A. (2022). Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. Ann Thorac Surg, 113(3), 942–948. https://doi.org/10.1016/j.athoracsur.2021.04.001
Rucker, A Justin, Vignesh Raman, Oliver K. Jawitz, Kristen E. Rhodin, Betty C. Tong, David H. Harpole, and Thomas A. D’Amico. “Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma.Ann Thorac Surg 113, no. 3 (March 2022): 942–48. https://doi.org/10.1016/j.athoracsur.2021.04.001.
Rucker AJ, Raman V, Jawitz OK, Rhodin KE, Tong BC, Harpole DH, et al. Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Mar;113(3):942–8.
Rucker, A. Justin, et al. “Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma.Ann Thorac Surg, vol. 113, no. 3, Mar. 2022, pp. 942–48. Pubmed, doi:10.1016/j.athoracsur.2021.04.001.
Rucker AJ, Raman V, Jawitz OK, Rhodin KE, Tong BC, Harpole DH, D’Amico TA. Impact of Time to Endoscopic Resection on Outcomes for Stage I Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Mar;113(3):942–948.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

March 2022

Volume

113

Issue

3

Start / End Page

942 / 948

Location

Netherlands

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Neoplasm Staging
  • Humans
  • Esophagectomy
  • Esophageal Neoplasms
  • Adenocarcinoma
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology